Xiaobing Ju
Papers
1
Total Citations
22
H-Index
1
About
Xiaobing Ju is a prominent researcher in urologic oncology, with a specialized focus on the comparative effectiveness of minimally invasive treatments for renal cell carcinoma. Their seminal 2014 systematic review and meta-analysis, which has garnered 22 citations, critically evaluated radiofrequency ablation versus partial nephrectomy for clinical stage 1 renal masses. This work provided essential evidence-based insights into the evolving treatment paradigm for small renal masses (SRMs), helping to clarify outcomes and guide clinical decision-making in an era of rising SRM incidence. Ju’s research addresses a pivotal shift in kidney cancer management, emphasizing the balance between oncologic control and nephron preservation. By synthesizing data from multiple studies, they have contributed significantly to the literature on ablation techniques and surgical approaches, influencing urologists and researchers alike. Their work remains a key reference for those exploring the efficacy and safety of these interventions, underscoring their impact on advancing personalized treatment strategies in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1